Please assess the completion status of the following clinical trial:

Trial Title: Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmatory cohort subjects who completed the 18F-AV-1451-A05 (NCT02016560) study~Exclusion Criteria:~* Current clinically significant cardiovascular disease, ECG abnormalities, risk factors for Torsades de Pointes (TdP), or are taking drugs known to cause QT prolongation~* Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer~* Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception~* Have had a non-study related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session~* Have received or participated in a trial with investigational medications in the past 30 days

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Follow-up Flortaucipir PET Scan (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).